Differential expression of CD44 splice variants in malignant and benign pleural effusions.

Expression of CD44 isoform that contains variant exons (v1-v10) has been implicated in tumor progression and metastasis. Especially, CD44 isoform containing v6 (CD44v6) and that containing v7 (CD44v7) were shown to confer full metastatic behavior on tumor cells. We examined the expression of CD44v6 and CD44v7 in malignant pleural effusions (13 lung cancers and 4 non-lung cancers) and in benign pleural effusions (7 tuberculosis and 3 pneumonia) with Southern blot analysis of reverse transcription (RT)-polymerase chain reaction (PCR) products. CD44v6 was expressed not only in malignant pleural effusions (12 of 13 lung cancers and 4 of 4 non-lung cancers), but also in benign pleural effusions(9/10). In contrast, although expression of CD44v7 was found in most malignant pleural effusions (12 of 13 lung cancers and 4 of 4 non-lung cancers), it was found in only a few cases of benign pleural effusions. These results suggest that the expression of CD44v7 may be correlated with a tumor-specific event such as metastasis or dissemination in malignant pleural effusion, while no such correlation can be found with CD44v6.

[1]  W. Lee,et al.  Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of chinese subjects , 1995, Cancer.

[2]  P. Herrlich,et al.  Comparison of immunohistochemistry and RT‐PCR for detection of CD44v‐expression, a new prognostic factor in human breast cancer , 1995, International journal of cancer.

[3]  L. Bourguignon,et al.  New CD44 splice variants associated with human breast cancers , 1995, Journal of cellular physiology.

[4]  J. Oosting,et al.  Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins , 1994, The Lancet.

[5]  R. Ueda,et al.  Expression of CD44 Variant Isoforms in Normal and Neoplastic Cells of the Lung , 1994, Japanese journal of cancer research : Gann.

[6]  X. Yang,et al.  Expression of CD44 in human lung tumors. , 1994, Cancer research.

[7]  H. Müller-Hermelink,et al.  Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. , 1993, Cancer research.

[8]  L. Ellis,et al.  Expression of CD44R1 adhesion molecule in colon carcinomas and metastases , 1993, The Lancet.

[9]  P. Herrlich,et al.  The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. , 1993, Cancer research.

[10]  P. Herrlich,et al.  Prevention of tumor metastasis formation by anti-variant CD44 , 1993, The Journal of experimental medicine.

[11]  P. Herrlich,et al.  A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps , 1993, The Journal of cell biology.

[12]  J. Bell,et al.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Tarin,et al.  Significance of CD44 gene products for cancer diagnosis and disease evaluation , 1992, The Lancet.

[14]  P. Herrlich,et al.  Participation in normal immune responses of a metastasis-inducing splice variant of CD44. , 1992, Science.

[15]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[16]  J. Bell,et al.  Expression of alternatively spliced forms of the CD44 extracellular‐matrix receptor on human lung carcinomas , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.